UNSPSC 41202003: Arizona spp. serological reagents

In this classification, Arizonagenus serological reagents are devices used in test to identify specific Arizonagenus antibodies in serum. US FDA regulates Arizonagenus serological reagents under 21 CFR 866.3035 and under FDA product code GTE.

UNSPSC 41202003 Arizona spp. serological reagents is a Commodity code covering rapid diagnostic test kits and laboratory reagents for HIV, Syphilis, and Hepatitis screening deployed across state public health departments, county criminal justice agencies, municipal health programs, and university student health centers. State and local buyers source these kits as one-time-use consumables for point-of-care or laboratory-based serology testing, typically bundling them with specimen collection staffing, automated screening platforms, confirmation assays (immunoassay, LC/MS/MS, or GC/MS), and electronic result reporting. Issuing bodies range from state health departments conducting high-volume procurement to county community supervision agencies managing offender drug and disease testing, municipal public health programs, and university health services. The Illinois Department of Public Health appears as a repeat buyer, conducting multiple solicitations for HIV/Syphilis reagents and instrumentation over the past six months.

Recent activity concentrates in Texas and Illinois. The City of Austin issued an IFB in June 2026 (due July 17) for Abbott Determine HIV 1/2 test kits—375 units annually at estimated prices—as a one-time consumable supply with all-inclusive pricing and optional small-business preference eligibility. Collin County Community Supervision and Corrections Department released an RFP in July 2026 (due July 23) for offender specimen collection and drug testing services encompassing immunoassay screening with confirmation, alternative methodologies including oral fluid and hair testing, and approximately 25,031 annual tests across five-panel and six-panel formats, with a $600,000 estimated contract value and a two-year initial term. The Illinois Department of Public Health issued an IFB in February 2026 (due March 16) for a fully automated five-year combination screening platform capable of simultaneous Hepatitis B/C, HIV-1/HIV-2, and Syphilis testing with approximately 3,300 Hepatitis B, 3,000 Hepatitis C, 13,200 HIV, and 11,000 Syphilis tests annually, requiring vendor-supplied instrumentation and all maintenance at no equipment cost. Illinois also conducted emergency sole-source procurements with Abbott Laboratories in February and May 2026 for HIV/Syphilis reagent kits totaling $38,079.50, driven by uninterrupted testing needs at the IDPH Carbondale Laboratory. The Texas Department of Criminal Justice issued an RFP in April 2026 (due May 13) for forensic laboratory testing services including serology and DNA analysis with expert witness testimony, requiring ANSI-ASQ ANAB or A2LA accreditation and per-test pricing for specimen analysis.